★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★Open research. Global perspectives.
JOURNAL INFORMATION

Author Guidelines

The American Journal of Agriculture and Biomedical Engineering

Explore Current Issue ↗

Author Guidelines

The American Journal of Agriculture and Biomedical Engineering (TAJABE)
ISSN: 2689-1018

The American Journal of Agriculture and Biomedical Engineering welcomes original research articles, review articles, and short communications in agriculture, biomedical engineering, and related interdisciplinary fields.

Manuscripts should make a clear scientific contribution, use appropriate methods, and present conclusions supported by evidence. Contributions within either agriculture or biomedical engineering are welcome, as are studies connecting these disciplines.

1. General Submission Requirements

  • Manuscripts must be written in clear English and submitted in an editable Microsoft Word format (.doc or .docx).

  • Submissions must be original and must not be under consideration by another journal.

  • All authors must approve the manuscript and agree to its submission.

  • Related publications, preprints, conference papers, and substantial overlap with earlier work must be disclosed.

  • Submit through the journal’s online submission system. Any alternative submission method must be confirmed by the editorial office.

An extended conference paper must cite the earlier publication, explain its additional contribution, and comply with applicable copyright conditions.

2. Manuscript Formatting

Use a consistent, readable layout throughout the manuscript:

  • Font: Times New Roman, 12-point.

  • Line spacing: Double spacing.

  • Margins: 2.54 cm (1 inch) on all sides.

  • Page numbering: Number all pages consecutively.

  • Headings: Use a clear hierarchy for sections and subsections.

  • Abbreviations: Define abbreviations at their first appearance.

  • Units: Use SI units where appropriate.

Provide tables and equations in editable form wherever possible. Define mathematical symbols. Use accepted scientific nomenclature and italicize genus and species names where appropriate.

3. Files Required for Submission

To support double-blind peer review, submit the following separately:

Title page: Include author names, affiliations, contact details, and identifying declarations.

Anonymized manuscript: Remove author names, affiliations, acknowledgements, and identifying information from the text and file properties. Refer to previous work objectively without revealing authorship.

Additional files: Provide figures, supplementary materials, datasets, code, and supporting documentation where relevant.

Do not include identifiable patient records, confidential consent forms, or restricted information in publicly accessible supplementary files.

4. Title Page

The title page should include:

  • A concise and informative article title.

  • Full names of all authors in the agreed order.

  • Department, institution, city, and country for each author.

  • Corresponding author’s name and email address.

  • ORCID iDs, where available.

  • Funding information and conflict-of-interest declarations.

  • Author contributions and acknowledgements.

The corresponding author is responsible for communication with the journal and sharing relevant updates with all coauthors.

5. Abstract and Keywords

Provide an abstract summarizing the research purpose, methods, principal findings, and conclusions. Explain the scientific contribution or practical relevance without overstating the results.

Avoid references and unexplained abbreviations in the abstract.

For original research, a structured abstract may use:

Background · Objective · Methods · Results · Conclusion

Reviews and short communications may use an unstructured abstract appropriate to their content.

Include four to six keywords describing the subject, methods, biological system, technology, or application.

6. Structure of Original Research Articles

Introduction

Explain the research background, relevant literature, knowledge gap, and objectives. Identify the agricultural, biological, or biomedical engineering problem addressed by the study.

Materials and Methods

Describe the methods sufficiently for assessment and reproducibility. Where applicable, include:

  • Research design, setting, and study dates.

  • Materials, biological specimens, equipment, and relevant specifications.

  • Sampling, controls, replication, and sample-size justification.

  • Experimental procedures and measurement methods.

  • Statistical analysis and software versions.

  • Computational models, assumptions, and validation procedures.

  • Ethics approval, informed consent, and research permissions.

For agricultural studies, describe relevant crop varieties, soil properties, climatic conditions, field layout, treatments, irrigation, and management practices.

For biomedical engineering studies, describe device architecture, sensors, calibration, signal processing, performance measures, safety considerations, and validation conditions.

Results

Present findings clearly and logically using text, tables, figures, and equations. Report relevant numerical results, uncertainty, and statistical outcomes.

Avoid unnecessary duplication between the text and visual material.

Discussion

Interpret the findings in relation to the objectives and previous research. Explain limitations, contextual factors, and practical implications.

Distinguish computational predictions, laboratory findings, field validation, and clinical evidence. Do not claim clinical effectiveness or broad agricultural applicability beyond the evidence presented.

Conclusion

Summarize the principal findings and their significance. Recommendations should follow directly from the evidence.

7. Other Article Types

Review Articles

Reviews should define their scope, critically assess existing knowledge, and identify limitations and research gaps.

Systematic reviews and meta-analyses must describe the search strategy, eligibility criteria, study selection, quality assessment, and synthesis methods. Provide protocol registration details where applicable.

Short Communications

Short communications should present focused findings or technical advances concisely while providing sufficient methodological detail and supporting evidence.

8. Tables, Figures, and Equations

  • Number tables and figures consecutively in the order they are cited.

  • Give each table a descriptive title and each figure a clear caption.

  • Label graph axes and include measurement units.

  • Explain abbreviations, symbols, and statistical indicators.

  • Supply high-resolution figures with legible labels.

  • Include scale bars in microscopy and other images where appropriate.

  • Number equations consecutively when referenced in the text.

  • Define variables and symbols at their first use.

  • Obtain permission for copyrighted material where required.

Images must not be altered in ways that conceal, exaggerate, or misrepresent findings. Relevant image adjustments must be disclosed.

9. References

Use a consistent numbered reference style, with sources numbered in the order of their first appearance in the text.

Include author names, source title, publication details, and DOI or persistent identifier where available.

Journal article format:

Author surname and initials. Article title. Journal title. Year;volume(issue) range or article number. DOI.

Cite datasets, software, standards, protocols, and other research resources where relevant. Identify preprints as preprints.

Authors must verify reference accuracy and ensure that each source supports the associated statement. Avoid irrelevant citations and excessive self-citation.

10. Human Research and Patient Consent

Research involving human participants, identifiable human material, or identifiable personal data must include appropriate ethics approval or exemption information where required.

Identify the approving committee, provide the approval reference where available, and explain how informed consent and privacy were addressed.

Identifiable patient images or case details require appropriate consent for publication. Consent to participate does not automatically constitute consent for publication.

For clinical trials, provide the registry name, registration number, and registration date. Any retrospective registration must be disclosed and explained.

11. Animal Research and Welfare

Animal studies must include relevant ethical approval information and describe safeguards to minimize pain, distress, and suffering.

Provide sufficient information about species, husbandry, procedures, and humane endpoints where applicable. Follow appropriate reporting guidance, such as ARRIVE, for animal research.

12. Fieldwork, Biological Materials, and Biosafety

Provide applicable permissions for field trials, sample collection, protected species, restricted sites, and regulated biological materials.

Identify the sources of biological materials and relevant collection, transfer, or use permissions. Describe biosafety and environmental safeguards where appropriate.

Studies involving pesticides, genetically modified organisms, pathogens, or hazardous materials must address applicable institutional and regulatory requirements.

13. Data, Code, and Supporting Materials

Include a data availability statement and, where relevant, a code availability statement.

Share supporting datasets, analytical code, protocols, or design information where feasible. Explain restrictions arising from privacy, confidentiality, licensing, or other legitimate requirements.

Label supplementary files clearly and refer to them in the manuscript. Apply suitable reporting guidelines according to the study design.

14. Required Declarations

Include the following statements, as applicable:

Funding: Identify financial support and explain the funder’s role.

Conflicts of Interest: Disclose relevant financial and non-financial interests, including employment, consultancy, patents, or relationships with manufacturers whose products are evaluated. State explicitly if none exist.

Author Contributions: Describe each author’s contribution.

Data Availability: Explain where supporting data can be accessed or why access is restricted.

Code Availability: Provide access details for relevant software or code, or explain restrictions.

Acknowledgements: Recognize contributions that do not qualify for authorship, with permission from the individuals named.

Ethics Approval, Consent, and Permissions: Provide relevant approval, exemption, consent, and permit information.

During double-blind review, identifying declarations should be supplied separately through the title page or submission fields.

15. Use of Artificial Intelligence

Disclose substantive use of generative AI in manuscript preparation, analysis, or content creation. Identify the tool and explain its purpose.

When AI forms part of the research method, describe the models, data, evaluation procedures, and limitations sufficiently for assessment.

AI tools cannot be listed as authors. Human authors remain responsible for accuracy, originality, references, and research integrity.

AI-generated content must not be presented as genuine experimental observations, field measurements, or patient records. Legitimate use of synthetic data must be clearly identified. Confidential information must be protected.

16. Peer Review and Revisions

Submissions undergo initial editorial assessment followed by double-blind peer review where suitable, normally involving at least two independent reviewers.

If revisions are requested, submit:

  • A revised manuscript.

  • A point-by-point response to reviewer and editor comments.

  • An explanation of changes and evidence-based reasons for any disagreement.

An invitation to revise does not guarantee acceptance.

17. Publication Charges

Any applicable Article Processing Charge, payment conditions, and available waivers or discounts are disclosed on the journal’s Article Processing Charges page.

Payment does not guarantee acceptance or influence editorial decisions.

18. Copyright and Open Access

Authors retain copyright in their work. Published articles are freely available under the Creative Commons Attribution 4.0 International License (CC BY 4.0), unless otherwise stated.

The license permits sharing and adaptation, including commercial reuse, provided that appropriate attribution is given, the license is linked, and changes are indicated.

Authors may deposit published articles in institutional or subject repositories without an embargo, with acknowledgement of the original publication.

19. Proofs and Corrections

Authors must check proofs carefully, including names, affiliations, scientific names, numerical results, equations, tables, figures, and references.

Substantial changes after acceptance require editorial approval. Authors must promptly report significant errors discovered before or after publication and cooperate in correcting the scholarly record.

Submission Checklist

Before submitting, confirm that:

  • The manuscript is original and is not under consideration elsewhere.

  • All authors have approved the submission.

  • The title page and anonymized manuscript are provided separately.

  • The abstract, keywords, references, tables, and figures are complete.

  • Methods, experimental conditions, and validation procedures are adequately described.

  • Ethics approval, consent, animal welfare information, and permits are included where applicable.

  • Patient privacy, biosafety, and confidentiality are addressed.

  • Funding, conflicts of interest, and author contributions are declared.

  • Data and code availability statements are provided where relevant.

  • Third-party permissions have been obtained where required.

  • Related publications and substantive AI use have been disclosed.

For submission assistance, contact the editorial office through the journal’s official Contact page.